{"id":"https://openalex.org/W2005678524","doi":"https://doi.org/10.1097/qco.0b013e32833f9fd0","title":"Potential new drugs for human African trypanosomiasis: some progress at last","display_name":"Potential new drugs for human African trypanosomiasis: some progress at last","alternate_titles":[],"publication_year":2010,"publication_date":"2010-09-15","ids":{"openalex":"https://openalex.org/W2005678524","doi":"https://doi.org/10.1097/qco.0b013e32833f9fd0","mag":"2005678524","pmid":"https://pubmed.ncbi.nlm.nih.gov/20844428"},"language":"en","primary_location":{"id":"doi:10.1097/qco.0b013e32833f9fd0","doi":"https://doi.org/10.1097/qco.0b013e32833f9fd0","is_oa":false,"landing_page_url":"https://doi.org/10.1097/qco.0b013e32833f9fd0","pdf_url":null,"source":{"id":"https://openalex.org/S67076826","display_name":"Current Opinion in Infectious Diseases","issn_l":"0951-7375","issn":["0951-7375","1080-7861","1473-6527"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Infectious Diseases","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005678524"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073175338","display_name":"Michael Peter Barrett","orcid":"https://orcid.org/0000-0001-9447-3519","observed_orcids":["https://orcid.org/0000-0001-9447-3519"]},"institutions":[{"id":"https://openalex.org/I4210094430","display_name":"Wellcome Centre for Molecular Parasitology","ror":"https://ror.org/00m7w8s72","country_code":"GB","type":"facility","lineage":["https://openalex.org/I4210094430","https://openalex.org/I7882870","https://openalex.org/I87048295"]},{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Michael P Barrett","raw_affiliation_strings":["Wellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, UK. michael.barrett@glasgow.ac.uk","Wellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, UK","e-mail: [email\u00a0protected]","fax: +44 141 3304600","to Michael P. Barrett, Wellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow G12 8TA, UK Tel: +44 141 3306904"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, UK. michael.barrett@glasgow.ac.uk","institution_ids":["https://openalex.org/I4210094430","https://openalex.org/I7882870"]},{"raw_affiliation_string":"Wellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, UK","institution_ids":["https://openalex.org/I4210094430","https://openalex.org/I7882870"]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +44 141 3304600","institution_ids":[]},{"raw_affiliation_string":"to Michael P. Barrett, Wellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow G12 8TA, UK Tel: +44 141 3306904","institution_ids":["https://openalex.org/I4210094430","https://openalex.org/I7882870"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5073175338"],"corresponding_institution_ids":["https://openalex.org/I4210094430","https://openalex.org/I7882870"],"apc_list":null,"apc_paid":null,"fwci":1.3072,"has_fulltext":false,"cited_by_count":72,"citation_normalized_percentile":{"value":0.76670201,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"23","issue":"6","first_page":"603","last_page":"608"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10890","display_name":"Trypanosoma species research and implications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10890","display_name":"Trypanosoma species research and implications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10823","display_name":"Research on Leishmaniasis Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10296","display_name":"Vector-borne infectious diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2405","display_name":"Parasitology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/human-african-trypanosomiasis","display_name":"sleeping sickness","score":0.9900000095367432},{"id":"https://openalex.org/keywords/melarsoprol","display_name":"melarsoprol","score":0.9570000171661377},{"id":"https://openalex.org/keywords/fexinidazole","display_name":"fexinidazole","score":0.9909999966621399},{"id":"https://openalex.org/keywords/nitroheterocycles","display_name":"nitroheterocycles","score":0.9580000042915344},{"id":"https://openalex.org/keywords/trypanosome-drug-resistance","display_name":"trypanosome drug resistance","score":0.6520000100135803},{"id":"https://openalex.org/keywords/lead-compound-screening","display_name":"lead compound screening","score":0.4309999942779541},{"id":"https://openalex.org/keywords/trypanocidal-activity","display_name":"trypanocidal activity","score":0.5410000085830688}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8352060317993164},{"id":"https://openalex.org/C2780722877","wikidata":"https://www.wikidata.org/wiki/Q424751","display_name":"Eflornithine","level":4,"score":0.7488201856613159},{"id":"https://openalex.org/C2778792689","wikidata":"https://www.wikidata.org/wiki/Q203133","display_name":"African trypanosomiasis","level":3,"score":0.6111825704574585},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5590298175811768},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5200707316398621},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.49327439069747925},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.4854453206062317},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4273946285247803},{"id":"https://openalex.org/C2778143080","wikidata":"https://www.wikidata.org/wiki/Q2443552","display_name":"Trypanosomiasis","level":2,"score":0.3383723497390747},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.20762377977371216},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1942727267742157},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10170993208885193},{"id":"https://openalex.org/C2777497464","wikidata":"https://www.wikidata.org/wiki/Q418834","display_name":"Spermidine","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000518","descriptor_name":"Eflornithine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001896","descriptor_name":"Boron Compounds","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D001896","descriptor_name":"Boron Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001896","descriptor_name":"Boron Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004351","descriptor_name":"Drug Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008549","descriptor_name":"Melarsoprol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009547","descriptor_name":"Nifurtimox","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009593","descriptor_name":"Nitroimidazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009593","descriptor_name":"Nitroimidazoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D010419","descriptor_name":"Pentamidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010419","descriptor_name":"Pentamidine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D014344","descriptor_name":"Trypanocidal Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D014344","descriptor_name":"Trypanocidal Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014344","descriptor_name":"Trypanocidal Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014346","descriptor_name":"Trypanosoma brucei brucei","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D014353","descriptor_name":"Trypanosomiasis, African","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014353","descriptor_name":"Trypanosomiasis, African","qualifier_ui":"Q000469","qualifier_name":"parasitology","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1097/qco.0b013e32833f9fd0","doi":"https://doi.org/10.1097/qco.0b013e32833f9fd0","is_oa":false,"landing_page_url":"https://doi.org/10.1097/qco.0b013e32833f9fd0","pdf_url":null,"source":{"id":"https://openalex.org/S67076826","display_name":"Current Opinion in Infectious Diseases","issn_l":"0951-7375","issn":["0951-7375","1080-7861","1473-6527"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Infectious Diseases","raw_type":"journal-article"},{"id":"pmid:20844428","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20844428","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in infectious diseases","raw_type":"Journal Article"},{"id":"pmh:oai:eprints.gla.ac.uk:47392","doi":null,"is_oa":false,"landing_page_url":"http://eprints.gla.ac.uk/47392/","pdf_url":null,"source":{"id":"https://openalex.org/S4210235606","display_name":"ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)","issn_l":"2622-8912","issn":["2622-8912","2622-8920"],"is_oa":false,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/I4405259220","host_organization_name":"Institut Agama Islam Negeri Langsa","host_organization_lineage":["https://openalex.org/I4405259220"],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Articles"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W10910567","https://openalex.org/W1522260031","https://openalex.org/W1538374398","https://openalex.org/W1833038589","https://openalex.org/W1967086390","https://openalex.org/W1967724535","https://openalex.org/W1971668778","https://openalex.org/W1972056284","https://openalex.org/W1979015967","https://openalex.org/W1985132183","https://openalex.org/W1991297784","https://openalex.org/W1991586721","https://openalex.org/W1999351578","https://openalex.org/W2002861077","https://openalex.org/W2012459221","https://openalex.org/W2033589371","https://openalex.org/W2033591223","https://openalex.org/W2038264047","https://openalex.org/W2044392264","https://openalex.org/W2046148059","https://openalex.org/W2054758984","https://openalex.org/W2064524507","https://openalex.org/W2071585875","https://openalex.org/W2084084945","https://openalex.org/W2090433748","https://openalex.org/W2104765579","https://openalex.org/W2114136125","https://openalex.org/W2120086125","https://openalex.org/W2122738561","https://openalex.org/W2139289108","https://openalex.org/W2139715928","https://openalex.org/W2142965981","https://openalex.org/W2146234112","https://openalex.org/W2148813938","https://openalex.org/W2149739510","https://openalex.org/W2151799620","https://openalex.org/W2151877638","https://openalex.org/W2155447723","https://openalex.org/W2155817635","https://openalex.org/W2159158593","https://openalex.org/W2165320275","https://openalex.org/W2165788511","https://openalex.org/W2319047125","https://openalex.org/W4211252435"],"related_works":["https://openalex.org/W2146329417","https://openalex.org/W2147973202","https://openalex.org/W1979126132","https://openalex.org/W123687192","https://openalex.org/W2077451644","https://openalex.org/W2222231103","https://openalex.org/W2889073384","https://openalex.org/W2102526494","https://openalex.org/W2155771090","https://openalex.org/W3008871853"],"abstract_inverted_index":{"PURPOSE":[0],"OF":[1],"REVIEW:":[2],"This":[3],"review":[4],"covers":[5],"recent":[6],"developments":[7,205],"towards":[8],"novel":[9],"treatments":[10],"for":[11,182,199],"human":[12],"African":[13],"trypanosomiasis":[14],"(HAT).":[15],"RECENT":[16],"FINDINGS:":[17],"Within":[18],"the":[19,26,69,79,164,178,218,224],"past":[20],"decade,":[21],"some":[22],"important":[23],"advances":[24],"in":[25,50,102,128,136,163,206],"treatment":[27],"of":[28,42,75,81,166,174],"HAT":[29],"have":[30,195],"been":[31,65],"made.":[32],"One":[33,85],"old":[34],"drug,":[35],"melarsoprol,":[36],"previously":[37],"administered":[38],"over":[39],"a":[40,43,51],"period":[41],"month":[44],"or":[45],"more,":[46],"is":[47],"now":[48],"given":[49],"10-day":[52],"regimen":[53],"greatly":[54],"reducing":[55,78],"hospital":[56],"costs.":[57],"A":[58,143],"combination":[59],"chemotherapy,":[60],"eflornithine":[61,76],"alongside":[62],"nifurtimox,":[63],"has":[64,116,156,169],"introduced":[66],"to":[67,105,222,228],"decrease":[68],"time":[70],"frame":[71],"and":[72,77,138,188],"overall":[73],"dosing":[74],"risk":[80],"drug":[82,208],"resistance":[83],"emerging.":[84],"new,":[86],"orally":[87],"available":[88,216],"diamidine":[89,113],"prodrug,":[90],"pafuramidine,":[91],"that":[92,120,211],"recently":[93,117],"completed":[94],"phase":[95],"III":[96],"clinical":[97,158,183],"trials,":[98],"disappointingly":[99],"was":[100,149],"halted":[101],"its":[103],"progress":[104],"clinic":[106],"when":[107],"unforeseen":[108],"toxicity":[109],"issues":[110],"emerged.":[111],"The":[112,203],"series,":[114],"however,":[115],"yielded":[118],"representatives":[119],"cure":[121],"second-stage":[122],"central":[123],"nervous":[124],"system":[125],"(CNS)-involved":[126],"infections":[127],"experimental":[129],"animals":[130],"while":[131],"showing":[132],"less":[133],"tissue":[134],"accumulation":[135],"mammals":[137],"thus":[139],"offer":[140],"considerable":[141],"promise.":[142],"nitroheterocycle,":[144],"fexinidazole,":[145],"whose":[146],"trypanocidal":[147,207],"activity":[148],"first":[150],"shown":[151],"nearly":[152],"30":[153],"years":[154,221],"ago,":[155],"entered":[157],"trials.":[159],"Another":[160],"approach,":[161],"grounded":[162],"use":[165],"pharmacokinetic":[167],"data,":[168],"brought":[170],"another":[171],"new":[172,204,212],"class":[173],"compound":[175,192],"based":[176],"on":[177],"oxaborole":[179],"scaffold":[180],"forward":[181],"candidacy.":[184],"Furthermore,":[185],"several":[186],"target-based":[187],"whole":[189],"organism-based":[190],"chemical":[191],"screening":[193],"campaigns":[194],"identified":[196],"promising":[197],"hits":[198],"lead":[200],"development.":[201],"SUMMARY:":[202],"discovery":[209],"mean":[210],"compounds":[213],"could":[214],"become":[215],"within":[217],"next":[219],"5":[220],"support":[223],"WHO":[225],"declared":[226],"campaign":[227],"eliminate":[229],"HAT.":[230]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005678524","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
